Response to: ‘Mandatory, cost-driven switching from originator etanercept to its biosimilar SB
<sub/>4</sub>
: possible fallout on non-medical switching’ by Cantini and Benucci

Response to: ‘Mandatory, cost-driven switching from originator etanercept to its biosimilar SB ₄ : possible fallout on non-medical switching’ by Cantini and Benucci

Glintborg, Bente; Loft, Anne Gitte; Omerovic, Emina; Hendricks, Oliver; Linauskas, Asta; Espesen, Jakob; Danebod, Kamilla; Jensen, Dorte Vendelbo; Nordin, Henrik; Dalgaard, Emil Barner; Chrysidis, Stavros; Kristensen, Salome; Raun, Johnny Lillelund; Lindegaard, Hanne; Manilo, Natalia; Jakobsen, Susanne Højmark; Hansen, Inger Marie Jensen; Dalsgaard Pedersen, Dorte; Sørensen, Inge Juul; Andersen, Lis Smedegaard; Grydehøj, Jolanta; Mehnert, Frank; Krogh, Niels Steen; Hetland, Merete Lund

期刊名称Annals of the Rheumatic Diseases
作者Glintborg, Bente; Loft, Anne Gitte; Omerovic, Emina; Hendricks, Oliver; Linauskas, Asta; Espesen, Jakob; Danebod, Kamilla; Jensen, Dorte Vendelbo; Nordin, Henrik; Dalgaard, Emil Barner; Chrysidis, Stavros; Kristensen, Salome; Raun, Johnny Lillelund; Lindegaard, Hanne; Manilo, Natalia; Jakobsen, Susanne Højmark; Hansen, Inger Marie Jensen; Dalsgaard Pedersen, Dorte; Sørensen, Inge Juul; Andersen, Lis Smedegaard; Grydehøj, Jolanta; Mehnert, Frank; Krogh, Niels Steen; Hetland, Merete Lund
印刷ISSN0003-4967
电子ISSN1468-2060
文件大小134.11KB
发表时间2018-12-20
DOI10.1136/annrheumdis-2018-214788

发现好书期刊，享受阅读乐趣

Response to: ‘Mandatory, cost-driven switching from originator etanercept to its biosimilar SB 4 : possible fallout on non-medical switching’ by Cantini and Benucci

Response to: ‘Mandatory, cost-driven switching from originator etanercept to its biosimilar SB ₄ : possible fallout on non-medical switching’ by Cantini and Benucci